Patient-Centric Solutions: Transforming the Spinal Muscular Atrophy Medicine Market

The spinal muscular atrophy medicine market was estimated at USD 1.26 billion in 2022 and is likely to grow at a CAGR of 13.44% during 2023-2028 to reach USD 2.68 billion in 2028.

Spinal Muscular Atrophy (SMA) is a very rare genetic disorder that affects the part of the central nervous system that controls voluntary muscle movements.